The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
The role of gasotransmittersNO,H2SandCOin myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning
Open accessAbstract
Ischaemic heart disease is one of the leading causes of morbidity and mortality worldwide. The development of cardioprotective therapeutic agents remains a partly unmet need and a challenge for both medicine and industry, with significant financial and social implications. Protection of the myocardium can be achieved by mechanical vascular occlusions such as preconditioning (PC), when brief episodes of ischaemia/reperfusion (I/R) are experienced prior to ischaemia; postconditioning (PostC), when the brief episodes are experienced at the immediate onset of reperfusion; and remote conditioning (RC), when the brief episodes are experienced in another vascular territory. The elucidation of the signalling pathways, which underlie the protective effects of PC,PostC and RC, would be expected to reveal novel molecular targets for cardioprotection that could be modulated by pharmacological agents to prevent reperfusion injury. Gasotransmitters includingNO, hydrogen sulphide (H 2 S) and carbon monoxide (CO) are a growing family of regulatory molecules that affect physiological and pathological functions.NO,H 2 SandCOshare several common properties; they are beneficial at low concentrations but hazardous in higher amounts; they relax smooth muscle cells, inhibit apoptosis and exert anti‐inflammatory effects. In the cardiovascular system,NO,H 2 SandCOinduce vasorelaxation and promote cardioprotection. In this review article, we summarize current knowledge on the role of the gasotransmittersNO,H 2 SandCOin myocardial I/R injury and cardioprotection provided by conditioning strategies and highlight future perspectives in cardioprotection byNO,H 2 S,CO, as well as their donor molecules. Linked Articles: This article is part of a themed section on Pharmacology of the Gasotransmitters. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-6
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I
Chouchani, E. T., Methner, C., Nadtochiy, S. M., Logan, A., Pell, V. R., Ding, S., James, A. M., Cochemé, H. M., Reinhold, J., Lilley, K. S., et al. (2013) · Nature Medicine · doi:10.1038/nm.3212 · Cited by 619 · cited 2×
“Moreover, a mitochondria-selective S-nitrosating agent, MitoSNO, has been shown to reduce the infarct size in mice (Chouchani et al., 2013).”
BackgroundWebb, A., Bond, R., McLean, P., Uppal, R., Benjamin, N., & Ahluwalia, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402927101 · Cited by 608 · cited 4×
“showed that the reduction of nitrite to NO was XOR-dependent (Webb et al., 2004), another research group demonstrated that myoglobin is the main nitrite reductase in the myocardium (Hendgen-Cotta et al.”
BackgroundResultInfluentialNitric oxide in myocardial ischemia/reperfusion injury
Schulz, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.019 · Cited by 462
Self-citationHendgen-Cotta, U. B., Merx, M. W., Shiva, S., Schmitz, J., Becher, S., Klare, J. P., Steinhoff, H.-J., Goedecke, A., Schrader, J., Gladwin, M. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801336105 · Cited by 418
Self-citationMitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain.
Zhang, J., & Piantadosi, C. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115980 · Cited by 320
Rassaf, T., Flögel, U., Drexhage, C., Hendgen-Cotta, U., Kelm, M., & Schrader, J. (2007) · Circulation Research · doi:10.1161/circresaha.107.152488 · Cited by 284
Self-citationNitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation
Totzeck, M., Hendgen-Cotta, U. B., Luedike, P., Berenbrink, M., Klare, J. P., Steinhoff, H.-J., Semmler, D., Shiva, S., Williams, D., Kipar, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.087155 · Cited by 202
Self-citationRole of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics
DEZFULIAN, C., RAAT, N., SHIVA, S., & GLADWIN, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.001 · Cited by 198 · cited 1×
“The administration of sodium nitrite exerts cytoprotective effects in myocardial I/R injury (Webb et al., 2004; Dezfulian et al., 2007; Hendgen-Cotta et al., 2008).”
BackgroundScragg, J. L., Dallas, M. L., Wilkinson, J. A., Varadi, G., & Peers, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803037200 · Cited by 133
Sobenin, I. A., Pryanishnikov, V. V., Kunnova, L. M., Rabinovich, Y. A., Martirosyan, D. M., & Orekhov, A. N. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-119 · Cited by 114
Hendgen-Cotta, U. B., Kelm, M., & Rassaf, T. (2010) · Nitric Oxide · doi:10.1016/j.niox.2009.10.003 · Cited by 46
Self-citation
Cited by
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
Targeting vascular (endothelial) dysfunction
Daiber, A., Steven, S., Weber, A., Shuvaev, V. V., Muzykantov, V. R., Laher, I., Li, H., Lamas, S., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13517 · Cited by 501
Szabo, C., & Papapetropoulos, A. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.014050 · Cited by 423
Self-citationROS-induced NO generation for gas therapy and sensitizing photodynamic therapy of tumor
Wan, S.-S., Zeng, J.-Y., Cheng, H., & Zhang, X.-Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.004 · Cited by 272
Daiber, A., Di Lisa, F., Oelze, M., Kröller‐Schön, S., Steven, S., Schulz, E., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13403 · Cited by 269
Metadata
- Authors
- Andreadou, I., Iliodromitis, E. K., Rassaf, T., Schulz, R., Papapetropoulos, A., & Ferdinandy, P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-09-23
- Volume
- 172
- Issue
- 6
- Pages
- 1587-1606
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1605590279
- Cited by
- 212
- References
- 11
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.